Advert - Novo Nordisk – Case AUTH/3717/12/22

• Date posted
  24 October 2024
• Sanction
  Advertisement,
• Case number/s
  AUTH/3717/12/22 - Complainant v Novo Nordisk

For its involvement in an article published in The Sunday Times in 2022, where a statement made by a global senior leader promoted a prescription only medicine to the public in a way that was misleading, Novo Nordisk was ruled in breach of the following clauses of the 2021 Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry
Clause 5.1 - Failing to maintain high standards
Clause 6.1 - Providing misleading information
Clause 26.1 - Promoting a prescription only medicine to the public
Clause 26.2 - Providing unbalanced information and encouraging members of the
public to ask their health professional for a specific prescription only medicine